Madison Investment Advisors LLC Purchases New Stake in Colgate-Palmolive (NYSE:CL)

Madison Investment Advisors LLC purchased a new stake in shares of Colgate-Palmolive (NYSE:CL) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 104,266 shares of the company’s stock, valued at approximately $9,479,000.

Several other institutional investors and hedge funds have also made changes to their positions in CL. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter valued at approximately $26,000. Centricity Wealth Management LLC acquired a new stake in Colgate-Palmolive in the fourth quarter worth $27,000. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive in the fourth quarter worth $32,000. Briaud Financial Planning Inc acquired a new stake in Colgate-Palmolive in the fourth quarter worth $32,000. Finally, Wintrust Investments LLC acquired a new stake in Colgate-Palmolive in the fourth quarter worth $33,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Down 0.4 %

Shares of CL stock opened at $90.41 on Friday. The stock has a 50-day simple moving average of $89.03 and a 200 day simple moving average of $94.93. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The stock has a market capitalization of $73.37 billion, a P/E ratio of 25.69, a P/E/G ratio of 4.20 and a beta of 0.40. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company posted $0.87 earnings per share. On average, sell-side analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Analyst Ratings Changes

CL has been the topic of several analyst reports. UBS Group dropped their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. TD Cowen dropped their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Barclays dropped their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Finally, JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $101.61.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.